Skip to main content

Table 4 Five-year recurrence-free survival of PDAC patients according to CDC20 expression level

From: Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression

CDC20 expressiona

N

5-year survival rate (%)

Mean survival duration, months (95% confidence interval)

Pb

Low

42

28.57

45.9 (26.9-64.9)

0.039

High

14

14.29

15.6 (1.8-29.4)

 
  1. a. The percentage of positive cells with CDC20 protein expression; cut off value is 4.93%
  2. b. log-rank (Kaplan-Meier) test, low versus high.